Pokroy Russell, Levinger Samuel, Hirsh Ami
Enaim Refractive Surgery Center, Jerusalem, Israel.
J Cataract Refract Surg. 2004 Aug;30(8):1685-95. doi: 10.1016/j.jcrs.2004.02.050.
To describe the visual outcome of implantation of a single Intacs segment (Addition Technology Inc.) in eyes with keratectasia after myopic laser in situ keratomileusis (LASIK).
Private refractive surgery center, Jerusalem, Israel.
This retrospective, noncomparative, interventional, consecutive, small case series studied 5 eyes of 5 patients with post-LASIK keratectasia from 3 refractive laser centers treated by Intacs implantation. Before and 9 months after Intacs implantation, the uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest refraction, keratometry, videokeratography, inferior-superior asymmetry, and patient questionnaires about visual function were assessed.
Intacs implantation was performed 17 to 32 months post LASIK with no intraoperative complications and no loss of visual acuity. After implantation, the UCVA improved 8, 4, 3, 0.5, and 5 lines and the BSCVA, 2, 2.5, 1, 0.5, and 2 lines. The mean manifest refraction spherical equivalent improved from -1.60 diopters (D) +/- 1.67 (SD) to -0.80 +/- 1.05 D. The mean manifest astigmatic correction decreased from -3.9 +/- 2.96 to -2.46 +/- 2.77 D. Corneal topography showed improved inferior steepening and less irregular astigmatism. The mean inferior-superior asymmetry improved from 7.88 +/- 4.59 to 2.46 +/- 2.77 D. Self-reported visual symptoms improved significantly in Cases 1, 2, and 5 and slightly in Cases 3 and 4.
Implantation of a single Intacs segment inferiorly appeared to improve progressive myopia and regular and irregular astigmatism in eyes with corneal ectasia after LASIK. With further study, this technique may prove to be an effective, relatively noninvasive approach.
描述在近视激光原位角膜磨镶术(LASIK)后发生角膜扩张的眼中植入单个Intacs角膜环(Addition Technology Inc.)的视觉效果。
以色列耶路撒冷的私立屈光手术中心。
本回顾性、非对照、干预性、连续性小病例系列研究了来自3个屈光激光中心的5例LASIK术后角膜扩张患者的5只眼,这些患者接受了Intacs植入治疗。在Intacs植入前和植入后9个月,评估了未矫正视力(UCVA)、最佳眼镜矫正视力(BSCVA)、显验光、角膜曲率测量、角膜地形图、上下不对称性以及患者关于视觉功能的问卷。
Intacs植入在LASIK术后17至32个月进行,术中无并发症,视力无下降。植入后,UCVA提高了8、4、3、0.5和5行,BSCVA提高了2、2.5、1、0.5和2行。平均显验光球镜等效度从-1.60屈光度(D)±1.67(标准差)提高到-0.80±1.05 D。平均显验光散光矫正从-3.9±2.96降低到-2.46±2.77 D。角膜地形图显示下方陡峭改善,不规则散光减少。平均上下不对称性从7.88±4.59改善到2.46±2.77 D。自我报告的视觉症状在病例1、2和5中显著改善,在病例3和4中略有改善。
在LASIK术后角膜扩张的眼中,下方植入单个Intacs角膜环似乎可改善进行性近视以及规则和不规则散光。随着进一步研究,该技术可能被证明是一种有效且相对无创的方法。